Main Industry
Health Care
Main Product/Service
Development of Oral and Intravenous Formulations for the New Colorectal Cancer Drug TG1
The content above was translated by Ai
Founded Year
2018
Unified Business No.
50904827
Status
Active
Number of Employees
0
Total Paid-in
Capital
5,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Research and development of oral and intravenous injection formulations and dosage forms for the new colorectal cancer drug TG1
The content above was translated by Ai
